{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:59:07Z","timestamp":1792670347111,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T00:00:00Z","timestamp":1489190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.psyneuen.2017.02.031","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T18:42:45Z","timestamp":1488480165000},"page":"46-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"special_numbering":"C","title":["Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)\u2014A randomized controlled trial"],"prefix":"10.1016","volume":"80","author":[{"given":"Marie","family":"Bixo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Ekberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger Sundstr\u00f6m","family":"Poromaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica Lind\u00e9n","family":"Hirschberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aino Fianu","family":"Jonasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta","family":"Andr\u00e9en","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Timby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Wulff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Ehrenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn","family":"B\u00e4ckstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2017.02.031_bib0005","series-title":"The Diagnostic and Statistical Manual of Mental Disorders","author":"APA","year":"2013"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00213-006-0417-0","article-title":"Allopregnanolone concentration and mood\u2013a bimodal association in postmenopausal women treated with oral progesterone","volume":"187","author":"Andreen","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0015","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.psyneuen.2009.02.003","article-title":"Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators","volume":"34","author":"Andreen","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00023210-200317050-00003","article-title":"The role of hormones and hormonal treatments in premenstrual syndrome","volume":"17","author":"Backstrom","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2005.01.049","article-title":"Isoallopregnanolone; an antagonist to the anaesthetic effect of allopregnanolone in male rats","volume":"512","author":"Backstrom","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0030","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0028-3908(02)00172-7","article-title":"The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors","volume":"43","author":"Belelli","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.psyneuen.2014.10.025","article-title":"Isoallopregnanolone antagonize allopregnanolone-induced effects on saccadic eye velocity and self-reported sedation in humans","volume":"52","author":"Bengtsson","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(97)00455-1","article-title":"Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states","volume":"764","author":"Bixo","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.forsciint.2005.06.009","article-title":"Flunitrazepam: psychomotor impairment, agitation and paradoxical reactions","volume":"159","author":"Bramness","year":"2006","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0050","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1517\/14728222.2014.897329","article-title":"Progesterone and its metabolites as therapeutic targets in psychiatric disorders","volume":"18","author":"Bristot","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0055","first-page":"1001","article-title":"Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486","volume":"84","author":"Chan","year":"1994","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0060","first-page":"435","article-title":"Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries","volume":"100","author":"Cohen","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0065","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.fertnstert.2009.04.023","article-title":"The effect of premenstrual symptoms on activities of daily life","volume":"94","author":"Dennerstein","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2125.2002.t01-10-01714.x","article-title":"Biomarkers for the effects of benzodiazepines in healthy volunteers","volume":"55","author":"de Visser","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0075","doi-asserted-by":"crossref","first-page":"178","DOI":"10.15288\/jsa.1996.57.178","article-title":"The effects of alcohol on the aggressive responding of women","volume":"57","author":"Dougherty","year":"1996","journal-title":"J. Stud. Alcohol"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00737-005-0103-y","article-title":"Daily record of severity of problems (DRSP): reliability and validity","volume":"9","author":"Endicott","year":"2006","journal-title":"Arch. Womens Ment. Health"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0085","first-page":"1219","article-title":"Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder","volume":"100","author":"Halbreich","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/00016348909020997","article-title":"A demographic study in subgroups of women seeking help for premenstrual syndrome","volume":"68","author":"Hammarback","year":"1989","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-008-1372-8","article-title":"Studies of pharmacokinetic and pharmacodynamic properties of isoallopregnanolone in healthy women","volume":"203","author":"Hedstrom","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0100","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archpsyc.1986.01800060032005","article-title":"Benzodiazepine sensitivity in normal human subjects","volume":"43","author":"Hommer","year":"1986","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1469-8986.1981.tb01542.x","article-title":"Two-year retest stability of eye tracking performance and a comparison of electro-oculographic and infrared recording techniques: evidence of EEG in the electro-oculogram","volume":"18","author":"Iacono","year":"1981","journal-title":"Psychophysiology"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0110","first-page":"CD006586","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","volume":"2","author":"Lopez","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neuroscience.2004.11.010","article-title":"Changes in GABA(A) receptor subunit expression in the midbrain during the oestrous cycle in Wistar rats","volume":"131","author":"Lovick","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0006-8993(03)02939-1","article-title":"Allopregnanolone-stimulated GABA-mediated chloride ion flux is inhibited by 3beta-hydroxy-5alpha-pregnan-20-one (isoallopregnanolone)","volume":"982","author":"Lundgren","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0125","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nn1469","article-title":"Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety","volume":"8","author":"Maguire","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0130","first-page":"CD001396","article-title":"Selective serotonin reuptake inhibitors for premenstrual syndrome","volume":"6","author":"Marjoribanks","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0135","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/npp.2015.246","article-title":"5alpha-reductase inhibition prevents the luteal phase increase in plasma allopregnanolone levels and mitigates symptoms in women with premenstrual dysphoric disorder","volume":"41","author":"Martinez","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/09513590701253511","article-title":"Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome","volume":"23","author":"Nyberg","year":"2007","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00737-010-0201-3","article-title":"Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus","volume":"14","author":"O'Brien","year":"2011","journal-title":"Arch. Womens Ment. Health"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0150","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1440-1681.2008.04946.x","article-title":"A comparison of the pharmacological properties of recombinant human and rat alpha(1)beta(2)gamma(2L) GABA(A) receptors in Xenopus oocytes","volume":"35","author":"Rahman","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.brainres.2014.12.026","article-title":"Neurosteroid effects at alpha4betadelta GABAA receptors alter spatial learning and synaptic plasticity in CA1 hippocampus across the estrous cycle of the mouse","volume":"1621","author":"Sabaliauskas","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199801223380401","article-title":"Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome","volume":"338","author":"Schmidt","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.psyneuen.2017.02.031_bib0165","first-page":"e131","article-title":"Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder","volume":"201","author":"Segebladh","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0170","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neuropharm.2005.04.026","article-title":"Short-term steroid treatment increases delta GABAA receptor subunit expression in rat CA1 hippocampus: pharmacological and behavioral effects","volume":"49","author":"Shen","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0175","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nn1868","article-title":"Reversal of neurosteroid effects at alpha4beta2delta GABAA receptors triggers anxiety at puberty","volume":"10","author":"Shen","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0180","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neuroscience.2013.08.033","article-title":"A stress steroid triggers anxiety via increased expression of alpha4betadelta GABAA receptors in methamphetamine dependence","volume":"254","author":"Shen","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuroscience.2006.07.031","article-title":"Neurosteroid modulation of allopregnanolone and GABA effect on the GABA-A receptor","volume":"143","author":"Stromberg","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/01674820009085589","article-title":"Compliance to antidepressant drug therapy for treatment of premenstrual syndrome","volume":"21","author":"Sundstrom-Poromaa","year":"2000","journal-title":"J. Psychosom. Obstet. Gynaecol."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0195","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1034\/j.1600-0412.2000.079005405.x","article-title":"Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives","volume":"79","author":"Sveindottir","year":"2000","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0200","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00213-005-0148-7","article-title":"Pharmacokinetic and behavioral effects of allopregnanolone in healthy women","volume":"186","author":"Timby","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0205","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00213-016-4258-1","article-title":"Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study","volume":"233","author":"Timby","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.psyneuen.2014.07.025","article-title":"Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: a systematic review","volume":"50","author":"Toffoletto","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0215","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.psyneuen.2007.03.009","article-title":"Effects of allopregnanolone on sedation in men, and in women on oral contraceptives","volume":"32","author":"van Broekhoven","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0220","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1523\/JNEUROSCI.1715-07.2007","article-title":"How progesterone impairs memory for biologically salient stimuli in healthy young women","volume":"27","author":"van Wingen","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0225","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuroscience.2011.04.042","article-title":"Gonadal hormone regulation of the emotion circuitry in humans","volume":"191","author":"van Wingen","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0230","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/00016349509021201","article-title":"Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study","volume":"74","author":"Wang","year":"1995","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0235","first-page":"1076","article-title":"Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one","volume":"81","author":"Wang","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0240","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2006.11.071","article-title":"3Beta-hydroxysteroids and pregnenolone sulfate inhibit recombinant rat GABA(A) receptor through different channel property","volume":"557","author":"Wang","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0245","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1067\/mje.2002.124572","article-title":"Central-nervous side effects of midazolam during transesophageal echocardiography","volume":"15","author":"Wenzel","year":"2002","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0250","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0033291701004925","article-title":"Prevalence, incidence and stability of premenstrual dysphoric disorder in the community","volume":"32","author":"Wittchen","year":"2002","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0255","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1471-0528.2004.00135.x","article-title":"The effectiveness of GnRHa with and without \u2018add-back' therapy in treating premenstrual syndrome: a meta analysis","volume":"111","author":"Wyatt","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.psyneuen.2017.02.031_bib0260","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet. Gynecol."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453016309180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453016309180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:55:14Z","timestamp":1759683314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453016309180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":52,"alternative-id":["S0306453016309180"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2017.02.031","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)\u2014A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2017.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}